The Walker-Nichols team has significant business development experience and understands the requirements of multinationals, speciality pharmaceutical companies and biotech companies. In evaluating a new opportunity to add to our licensing portfolio, we generally look for those that: - demonstrate clear competitive advantages over existing treatments or fulfil an unmet medical need
- are protected by national / PCT patent filings that include Europe and the US and cover composition of matter
Please contact us if you are interested in adding your product/compound to our portfolio.
| 
+852 6200 8250
